Publications
Detailed Information
Hypoxia accelerates vascular repair of endothelial colony-forming cells on ischemic injury via STAT3-BCL3 axis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sang Hun | - |
dc.contributor.author | Lee, Jun Hee | - |
dc.contributor.author | Han, Yong-Seok | - |
dc.contributor.author | Ryu, Jung Min | - |
dc.contributor.author | Yoon, Yeo Min | - |
dc.contributor.author | Han, Ho Jae | - |
dc.date.accessioned | 2017-03-23T05:26:41Z | - |
dc.date.available | 2017-03-23T14:32:42Z | - |
dc.date.issued | 2015-07-29 | - |
dc.identifier.citation | Stem Cell Research & Therapy, 6(1):139 | ko_KR |
dc.identifier.uri | https://hdl.handle.net/10371/109955 | - |
dc.description.abstract | Introduction
Endothelial colony-forming cells (ECFCs) significantly improve tissue repair by providing regeneration potential within injured cardiovascular tissue. However, ECFC transplantation into ischemic tissue exhibits limited therapeutic efficacy due to poor engraftment in vivo. We established an adequate ex vivo expansion protocol and identified novel modulators that enhance functional bioactivities of ECFCs. Methods To augment the regenerative potential of ECFCs, functional bioactivities of hypoxia-preconditioned ECFCs (hypo-ECFCs) were examined. Results Phosphorylations of the JAK2/STAT3 pathway and clonogenic proliferation were enhanced by short-term ECFC culturing under hypoxia, whereas siRNA-targeting of STAT3 significantly reduced these activities. Expression of BCL3, a target molecule of STAT3, was increased in hypo-ECFCs. Moreover, siRNA inhibition of BCL3 markedly reduced survival of ECFCs during hypoxic stress in vitro and ischemic stress in vivo. In a hindlimb ischemia model of ischemia, hypo-ECFC transplantation enhanced blood flow ratio, capillary density, transplanted cell proliferation and survival, and angiogenic cytokine secretion at ischemic sites. Conclusions Hypoxia preconditioning facilitates functional bioactivities of ECFCs by mediating regulation of the STAT3-BCL3 axis. Thus, a hypoxic preconditioned ex vivo expansion protocol triggers expansion and functional bioactivities of ECFCs via modulation of the hypoxia-induced STAT3-BCL3 axis, suggesting that hypo-ECFCs offer a therapeutic strategy for accelerated neovasculogenesis in ischemic diseases. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BioMed Central | ko_KR |
dc.title | Hypoxia accelerates vascular repair of endothelial colony-forming cells on ischemic injury via STAT3-BCL3 axis | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이상훈 | - |
dc.contributor.AlternativeAuthor | 이준희 | - |
dc.contributor.AlternativeAuthor | 한용석 | - |
dc.contributor.AlternativeAuthor | 류정민 | - |
dc.contributor.AlternativeAuthor | 윤여민 | - |
dc.contributor.AlternativeAuthor | 한호재 | - |
dc.identifier.doi | 10.1186/s13287-015-0128-8 | - |
dc.language.rfc3066 | en | - |
dc.rights.holder | Lee et al. | - |
dc.date.updated | 2017-01-06T10:50:09Z | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.